KIMS corrects financial metrics of two acquisition targets

Revenue growth above 20%Exceptional itemResults View source PDF Explain this filing

KIMS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.0%Reaction day

₹693.15

prior close

₹695.00

announcement price

In-mkt

timing

Nifty Smallcap 250market+0.1%-0.1% vs market

Hospital peers, median of 26sector-0.3%+0.3% vs sector

On the reaction day the stock moved 0.1 pts less than Nifty Smallcap 250 and 0.3 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.1

10m

-0.1

15m

-0.1

30m

-0.2

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.0+0.1-0.1-0.3+0.3

Next day

-0.8-2.3+1.6-2.8+2.0

+1.8-1.8+3.6-1.6+3.4

+1.0-0.7+1.7-1.4+2.4

+1.9-0.4+2.3-3.2+5.1

-0.2-0.4+0.2-2.5+2.3

-1.1-1.5+0.3-3.6+2.4

15d

+1.4-4.5+5.8-4.9+6.3

—————

UpDownMarket · Nifty Smallcap 250Sector · Hospital peers, median of 26Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

KIMS has corrected typographical errors in financial metrics of two acquisition targets disclosed earlier. Insignia Healthcare Net Worth was overstated at 243.3 crore, now read as 24.3 crore. Insignia turnover was overstated at 104.5 crore, now 9.68 crore. Sarvottam Health Care PAT was overstated at 70.55 crore, now 7.06 crore. All other terms and figures remain unchanged.

Likely market impact

Material downward revision of target metrics may affect deal valuation and shareholder view of the acquisition.

By the numbersConsolidated · Q2 FY27 vs Q2 FY26

	Q2 FY27	Q2 FY26	Change
Revenue	₹1,344 Cr	₹960.7 Cr	+39.9%
Operating profit	₹74.10 Cr	₹92.90 Cr	−20.2%
Profit after tax	₹74.60 Cr	₹72.00 Cr	+3.6%
EBITDA margin	20.3%	21.2%	−0.9 pp

From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.